Demographic, medical, and behavioral characteristics associated with over the counter non- steroidal anti- inflammatory drug use in a population- based cohort: Results from the Multi- Ethnic Study of Atherosclerosis

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 1, 2011, Pages 83-89

  Delaney, Joseph A C ^a,b   Biggs, Mary L ^b   Kronmal, Richard A ^b   Psaty, Bruce M ^c,d  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d GROUP HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Aspirin; Ethnicity; Multi Ethnic Study of Atherosclerosis; Over the counter drug use

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; IBUPROFEN; NAPROXEN; NON PRESCRIPTION DRUG;

ARTICLE; BODY MASS; DIABETES MELLITUS; DRUG USE; EDUCATIONAL STATUS; ETHNICITY; GROUPS BY AGE; HEALTH INSURANCE; INCOME; PRESCRIPTION; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CLINICAL TRIALS AS TOPIC; ETHNIC GROUPS; FEMALE; HEALTH STATUS; HUMANS; IBUPROFEN; MALE; MIDDLE AGED; NAPROXEN; NONPRESCRIPTION DRUGS; PAIN; PRESCRIPTION DRUGS; UNITED STATES;

EID: 78650314899     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2065     Document Type: Article

References (23)

1. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex- specific meta- analysis of randomized controlled trials. JAMA 2006; 295(3): 306-313.
2. Berger JS, Brown DL, Becker RC. Low- dose aspirin in patients with stable cardiovascular disease: a meta- analysis. Am J Med 2008; 121(1): 43-49.
3. Vane JR, Botting RM. The mechanism of action of aspirin. Thromb Res 2003; 110(5-6): 255-258.
4. Paulose- Ram R, Hirsch R, Dillon C, Gu Q. Frequent monthly use of selected non- prescription and prescription non- narcotic analgesics among U.S. adults. Pharmacoepidemiol Drug Saf 2005; 14(4): 257-266.
5. Heard K, Sloss D, Weber S, Dart RC. Overuse of over- the- counter analgesics by emergency department patients. Ann Emerg Med 2006; 48(3): 315-318.
6. Saunders E, Ofili E. Epidemiology of atherothrombotic disease and the effectiveness and risks of antiplatelet therapy: race and ethnicity considerations. Cardiol Rev 2008; 16(2): 82-88.
7. Delaney JA, Opatrny L, Brophy JM, Suissa S. Interactions between anti- thrombotic drugs and the risk of gastro- intestinal haemorrhage. CMAJ 2007; 177(4): 347-351.
8. Hernández- Díaz S, García Rodríguez LA. Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med 2006; 4: 22.
9. Buresly K, Eisenberg MJ, Zhang X, Pilote L. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Arch Intern Med 2005; 165(7): 784-789.
10. Lévesque LE, Brophy JM, Zhang B. The risk for myocardial infarction with cyclooxygenase- 2 inhibitors: a population study of elderly adults. Ann Intern Med 2005; 142(7): 481-489.
11. Ilkhanoff L, Lewis JD, Hennessy S, Berlin JA, Kimmel SE. Potential limitations of electronic database studies of prescription non- aspirin non- steroidal anti- inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI). Pharmacoepidemiol Drug Saf 2005; 14(8): 513-522.
12. Bild DE, Bluemke DA, Burke GL, et al. Multi- ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156(9): 871-881.
13. Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, Lyles M. Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group. J Clin Epidemiol 1992; 45(6): 683-692.
14. Smith NL, Psaty BM, Heckbert SR, Tracy RP, Cornell ES. The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly. J Clin Epidemiol 1999; 52: 143-146.
15. Bertoni AG, Chung H, Whitt- Glover M, et al. The association between physical activity and subclinical atherosclerosis: the Multi- Ethnic Study of Atherosclerosis (MESA). Am J Epidemiol 2009; 169 (4): 444-454.
16. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702-706.
17. Filion KB, Delaney JA, Brophy JM, Ernst P, Suissa S. The impact of over- the- counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database. Pharmacoepidemiol Drug Saf 2007; 16(1): 1-4.
18. Artz MB, Harnack LJ, Duval SJ, Armstrong C, Arnett DK, Luepker RV. Use of nonprescription medications for perceived cardiovascular health. Am J Prev Med 2006; 30(1): 78-81.
19. Curhan GC, Bullock AJ, Hankinson SE, Willett WC, Speizer FE, Stampfer MJ. Frequency of use of acetaminophen, nonsteroidal anti- inflammatory drugs, and aspirin in US women. Pharmacoepidemiol Drug Saf 2002; 11(8): 687-693.
20. Suissa S, Garbe E. Primer: administrative health databases in observational studies of drug effects- advantages and disadvantages. Nat Clin Pract Rheumatol 2007; 3(12): 725-732.
21. Manolio TA, Burke GL, Psaty BM, et al. Black- white differences in subclinical cardiovascular disease among older adults: the Cardiovascular Health Study. CHS Collaborative Research Group. J Clin Epidemiol 1995; 48(9): 1141-1152.
22. Delaney JA, Moodie EE, Suissa S. Modeling blood pressures changes after drug treatment in the general practice research database. Pharmacoepidemiol Drug Saf 2008; 17(6): 535-545.
23. Ray WA. Evaluating medication effects outside of clinical trials: new- user designs. Am J Epidemiol 2003; 158(9): 915-920.